Upgrade to SI Premium - Free Trial

DepoMed Inc (DEPO) PT Lowered to $6 at RBC Capital Following 3Q Miss

November 8, 2017 8:13 AM
RBC Capital lowered its price target on DepoMed Inc (NASDAQ: DEPO) to $6.00 (from $8.00) while maintaining a Sector ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles